Peer-influenced content. Sources you trust. No registration required. This is HCN.

Features:
CME JOBS OUTBREAKS PEER-TO-PEER QUIZZES & QUESTIONS MEDTECH

Northwestern MedicineEpigenetic ‘Priming’ Boosts Ovarian Cancer Immunotherapy

An epigenetic inhibitor can boost immune system activity in patients with ovarian cancer, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.

Was this Essential useful?

More Essentials From

ACP Internist
ASH Clinical News
Annals of Internal Medicine
British Medical Journal
Cleveland Clinic Journal of Medicine
Clinical Advances in Hematology & Oncology
GoodRx Health
Healthgrades for Professionals
JAMA Network
Journal of Clinical Oncology
KevinMD.com
MedPage Today
Medical Professionals Reference (MPR)
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form